In our study, we found that PLK2 was significantly down-regulated in 529 GBM tissues compared to 10 normal non-tumor tissues (log2FC = −1.479; P-value < 0.0001; Fig. 1A) on AffyU133a platform. This evidence concerns the gene PLK2 and glioblastoma.